Kristina service was excellent
In the U.S, about 70% of adults are obese or overweight, and many of these people have serious health problems that put them at greater risk for heart disease, stroke, diabetes and some types of cancer
What we are seeing here is the end of the calorie economy, she told the F&A Next Summit in Wageningen, the Netherlands, with the performance nutrition economy taking its place
Small-scale clinical trials revealed that GLP-1 and GLP-1-based medicines may have positive effects on low-grade inflammation, blood pressure, cholesterol, and microcirculation ( Due to their various modes of action, which include vasodilation, natriuresis, glucose and weight control, and direct cardioprotective effects, GLP-1 receptor agonists have therapeutic potential for treatment of heart failure ( Obesity is a major cause of cardiovascular diseases
Franklin, T
Yu et al., 2018